Thromophilia Screening

The Thrombophilia Screening Test is a group of laboratory investigations used to evaluate conditions that may increase the tendency of blood to form abnormal clots.

Thrombophilia can be inherited or acquired and may be associated with conditions such as deep vein thrombosis (DVT), pulmonary embolism, and recurrent pregnancy complications.

This screening helps healthcare professionals investigate possible abnormalities in the blood-clotting system.

What Does This Test Check?

• Helps investigate an increased tendency for abnormal blood clot formation.

• Supports the evaluation of suspected inherited or acquired thrombophilia.

• May assist in investigating unexplained or recurrent blood clots.

• Helps assess possible clotting-related complications.

• Supports further evaluation when there is a personal or family history of thrombosis.

Sample Requirements

• Sample Type: Clotted Blood and PT (as listed by laboratory)

• Required Quantity: To be confirmed by the laboratory

• Department: Haematology / Coagulation

Patient Preparation

• Inform your healthcare provider about anticoagulant medications, including warfarin, heparin, or other blood thinners.

• Mention any previous history of blood clots or pregnancy-related complications.

• Follow specific collection instructions provided by the laboratory.

• Do not stop prescribed medication without medical advice.

Important Information

Thrombophilia screening may include different tests depending on the laboratory panel, such as Protein C, Protein S, Antithrombin III, and antiphospholipid antibodies. Not every screening package includes all these investigations.

Results should be interpreted alongside medical history, medication use, and clinical findings. Some tests may be affected by anticoagulant treatment or recent clotting events.

Reporting Time: To be confirmed by the laboratory.

Please confirm test availability, exact panel components, and sample collection requirements with the laboratory before booking.